Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
Authors
Keywords
-
Journal
PLoS One
Volume 5, Issue 7, Pages e11838
Publisher
Public Library of Science (PLoS)
Online
2010-07-29
DOI
10.1371/journal.pone.0011838
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease
- (2014) X. Hu et al. JOURNAL OF IMMUNOLOGY
- The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
- (2014) N. G. Innamorato et al. JOURNAL OF IMMUNOLOGY
- The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
- (2009) Antonio Cuadrado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
- (2009) Ana I. Rojo et al. GLIA
- Physiological and Pathological Role of Alpha-synuclein in Parkinson’s Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element
- (2009) David Olivares et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement
- (2009) Hyman M. Schipper et al. JOURNAL OF NEUROCHEMISTRY
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- (2009) Pei-Chun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opposite Expression of the Antioxidant Heme Oxygenase-1 in Primary Cells and Tumor Cells: Regulation by Interaction of USF-2 and Fra-1
- (2008) Anatoly Samoylenko et al. ANTIOXIDANTS & REDOX SIGNALING
- Iron, the substantia nigra and related neurological disorders
- (2008) Amanda M. Snyder et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Glutathione and Parkinson's disease: Is this the elephant in the room?
- (2008) Gail D. Zeevalk et al. BIOMEDICINE & PHARMACOTHERAPY
- Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections
- (2008) Antonio Cuadrado et al. CURRENT PHARMACEUTICAL DESIGN
- Carbon monoxide, reactive oxygen signaling, and oxidative stress
- (2008) Claude A. Piantadosi FREE RADICAL BIOLOGY AND MEDICINE
- Overexpression of Heme Oxygenase-1 Protects Dopaminergic Neurons against 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity
- (2008) S.-Y. Hung et al. MOLECULAR PHARMACOLOGY
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
- (2008) J. Salazar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain iron pathways and their relevance to Parkinson's disease
- (2003) D Berg et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More